Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion +2,700 25,063
2023-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion +10,617 35,680
2023-02-28 Alexander Kristen VP, Finance and Accounting Shares withheld for taxes −5,330 $2.17 $12K 30,350
2023-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion · Restricted Stock Units −5,400 0
2023-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion · Restricted Stock Units −2,700 2,700
2023-02-28 Alexander Kristen VP, Finance and Accounting Exercise or conversion · Restricted Stock Units −10,617 21,233
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion +14,833 36,700
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion +5,286 41,986
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion +22,963 64,949
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Shares withheld for taxes −11,813 $2.17 $26K 53,136
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion · Restricted Stock Units −14,833 0
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion · Restricted Stock Units −5,286 5,287
2023-02-28 Seth Kiernan VP, Chief Commercial Officer Exercise or conversion · Restricted Stock Units −22,963 45,927
2023-02-28 McDermott Wendy VP, Human Resources Exercise or conversion +18,943 18,943
2023-02-28 McDermott Wendy VP, Human Resources Shares withheld for taxes −6,465 $2.17 $14K 12,478
2023-02-28 McDermott Wendy VP, Human Resources Exercise or conversion · Restricted Stock Units −18,943 37,887
2023-02-28 MAIN ALAN J EVP, Innov & Chem Sciences Exercise or conversion +23,300 198,889
2023-02-28 MAIN ALAN J EVP, Innov & Chem Sciences Exercise or conversion +8,976 207,865
2023-02-28 MAIN ALAN J EVP, Innov & Chem Sciences Exercise or conversion +25,667 233,532
2023-02-28 MAIN ALAN J EVP, Innov & Chem Sciences Shares withheld for taxes −20,946 $2.17 $45K 212,586

Page 18 of 27 · 540 trades